QUIA PHARMA AB (FRA:99B0) Buyback Yield %: -325.27 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is QUIA PHARMA AB Buyback Yield %?

QUIA PHARMA AB FRA:99B0 Buyback Yield % is -325.27 as of Jul. 15, 2026. The stock has 3 warning signs investors should review.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

QUIA PHARMA AB's current buyback yield was -325.27%.

QUIA PHARMA AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for QUIA PHARMA AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QUIA PHARMA AB Buyback Yield % Chart

QUIA PHARMA AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.28 -20.78 -79.96 -216.00 -151.27

QUIA PHARMA AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -65.02 -277.70 -22.31 -132.58 -42.79

FRA:99B0 vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, QUIA PHARMA AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QUIA PHARMA AB Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's Buyback Yield % falls into.


QUIA PHARMA AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

QUIA PHARMA AB's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 2.037) / 1.3466292
=-151.27%

QUIA PHARMA AB's annualized Buyback Yield for the quarter that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.373) / 0.2620378
=-142.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -325.27 mean?
QUIA PHARMA AB (FRA:99B0) has a Buyback Yield % of -325.27 as of Jul. 15, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on QUIA PHARMA AB and its competitors.
Is QUIA PHARMA AB's Buyback Yield % too high?
QUIA PHARMA AB's current Buyback Yield % is -325.27.
How does QUIA PHARMA AB's Buyback Yield % compare to VRTX and REGN?
QUIA PHARMA AB's Buyback Yield % of -325.27 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on QUIA PHARMA AB and its competitors. QUIA PHARMA AB's current Buyback Yield % is -325.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QUIA PHARMA AB stock overvalued right now?
QUIA PHARMA AB (FRA:99B0) has a current Buyback Yield % of -325.27. The current Buyback Yield % is -325.27. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For QUIA PHARMA AB (FRA:99B0), the current Buyback Yield % is -325.27 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QUIA PHARMA AB Business Description

Address Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.